UBS Oncology Impact Fund, Former 10% Owner: Werewolf Therapeutics HOWL Planned sale · Filed 07/06

Trade details

Type: Planned sale notice
Stock: Werewolf Therapeutics HOWL
Person: UBS Oncology Impact FundFormer 10% Owner
Planned sale date: 26/07/06
Filed: 26/07/06

0.2% of shares outstanding to be sold

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 06/06~08/05

UBS Oncology Impact Fund's recent trades

UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$28.4K
87,916 sh
$28.4K
Filed 06/29
Traded 06/29
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$99K
202,029 sh
$99K
Filed 05/28
Traded 05/28
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$123.8K
240,280 sh
$123.8K
Filed 05/18
Traded 05/18
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$47.5K
69,904 sh
$47.5K
Filed 05/11
Traded 05/11
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$216.5K
300,821 sh
$216.5K
Filed 05/01
Traded 05/01

UBS Oncology Impact Fund, 10% Owner — plans to sell 80,142 sh of Werewolf Therapeutics HOWL · $27.3K · around 07/06 · 10b5-1 plan | Whalegun